In murine triple negative breast cancer models, Colony-Stimulating Factor-1 Receptor (CSF-1R) inhibitors reduced tumor-associated macrophage-mediated suppression and enhanced response to anti-PD-1 therapy [4]. This evidence concerns the gene CSF1R and triple-negative breast carcinoma.